HIGHLIGHTS
- who: Giovanni Marasco and colleagues from the Division of Internal Medicine and Digestive Pathophysiology, IRCCS Azienda Ospedaliero-Universitaria Bologna, Bologna, Italy Department of Medical and Surgical Science, University of Bologna, Bologna, Italy have published the Article: A Nomogram-Based Prognostic Model for Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib: A Multicenter Study, in the Journal: Cancers 2021, x of 31/03/2021
- what: The authors aimed to evaluate predictive factors of overall survival (OS) and drug response in HCC patients undergoing Sorafenib included in the Italian Liver Cancer (ITA.LI.CA.) multicenter cohort. The patient . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.